Ontogeny of bilirubin-binding capacity and the effect of clinical status in premature infants born at less than 1300 grams

Pediatrics

Volumn 120, Issue 5, 2007, Pages 1067-1073

  Bender, George Jesse ^a   Cashore, William James ^a   Oh, William ^a  

^a WOMEN AND INFANTS HOSPITAL   (United States)

Author keywords

Bilirubin encephalopathy; Bilirubin binding affinity; Bilirubin binding capacity; Kernicterus

Indexed keywords

ALBUMIN; BILIRUBIN; BROMCRESOL PURPLE;

ANALYZER; ARTICLE; BILIRUBIN BINDING; BILIRUBIN BLOOD LEVEL; BINDING AFFINITY; COHORT ANALYSIS; FEMALE; GESTATIONAL AGE; HIGH RISK POPULATION; HUMAN; HYPERBILIRUBINEMIA; KERNICTERUS; MAJOR CLINICAL STUDY; MALE; NEWBORN; ONTOGENY; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; VERY LOW BIRTH WEIGHT;

APGAR SCORE; BILIRUBIN; COHORT STUDIES; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; MALE; PROTEIN BINDING; SERUM ALBUMIN;

EID: 36048961367     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2006-3024     Document Type: Article

References (29)

1. Wennberg RP, Ahlfors CE, Bhutani VK, Johnson LH, Shapiro SM. Toward understanding kernicterus: a challenge to improve the management of jaundiced newborns [published correction appears in Pediatrics. 2006;117:1467]. Pediatrics. 2006;117:474-485
2. Ostrow JD, Pascolo L, Shapiro SM, Tiribelli C. New concepts in bilirubin encephalopathy. Eur J Clin Invest. 2003;33:988-997
3. Cashore WJ, Horwich A, Karotkin EH, Oh W. Influence of gestational age and clinical status on bilirubin-binding capacity in newborn infants. Am J Dis Child. 1977;131:898-901
4. Lemons JA, Bauer CR, Oh W, et al. Very low birth weight outcomes of the National Institute of Child Health and human development neonatal research network, January 1995 through December 1996. NICHD Neonatal Research Network. Pediatrics. 2001;107(1). Available at: www.pediatrics.org/cgi/content/ full/107/1/e1
5. Oh W, Tyson JE, Fanaroff AA, et al. Association between peak serum bilirubin and neurodevelopmental outcomes in extremely low birth weight infants. Pediatrics. 2003;112:773-779
6. Shimabuku R, Nakamura H. Total and unbound bilirubin determination using an automated peroxidase micromethod. Kobe J Med Sci. 1982;28:91-104
7. Pinnell AE, Northam BE. New automated dye-binding method for serum albumin determination with bromcresol purple. Clin Chem. 1978;24:80-86
8. Graphpad Prism 4 for Windows [computer program]. San Diego, CA: GraphPad Software, Inc; 2005
9. Richardson DK, Corcoran JD, Escobar GJ, Lee SK. SNAP-II and SNAPPE-II: Simplified newborn illness severity and mortality risk scores. J Pediatr. 2001;138:92-100
10. Bhutani VK, Johnson LH, Maisels J, Newman TB. Kernicterus: epidemiological strategies for its prevention through systems-based approaches. J Perinatol. 2004;24:650-662
11. American Academy of Pediatrics, Provisional Committee for Quality Improvement and Subcommittee on Hyperbilirubinemia. Practice parameter: management of hyperbilirubinemia in the healthy term newborn [published correction appears in Pediatrics. 1995;9:458-461]. Pediatrics. 1994;94:558-565
12. American Academy of Pediatrics, Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation [published correction appears in Pediatrics. 2004;114:1138]. Pediatrics. 2004;114:297-316
13. Bratlid D. Criteria for treatment of neonatal jaundice. J Perinatol. 2001;21:S88-S92
14. Cashore WJ. Bilirubin and jaundice in the micropremie. Clin Perinatol. 2000;27:171-179
15. Gartner LM, Snyder RN, Chabon RS. Kernicterus: high incidence in premature infants with low serum bilirubin concentrations. Pediatrics. 1970;45:906-917
16. Ahdab-Barmada M, Moossy J. The neuropathology of kernicterus in the premature neonate: diagnostic problems. J Neuropathol Exp Neurol. 1984;43:45-56
17. Penn AA, Enzmann DR, Hahn JS, Stevenson DK. Kernicterus in a full term infant. Pediatrics. 1994;93:1003-1006
18. Govaert P, Lequin M, Swarte R, et al. Changes in globus pallidus with (pre)term kernicterus. Pediatrics. 2003;112:1256-1263
19. Ahlfors C. Unbound bilirubin associated with kernicterus: a historical approach. J Pediatr. 2000;137:540-544
20. Nakamura H, Takada S, Shimabuku R, Matsuo M, Matsuo T, Negishi H. Auditory nerve and brainstem responses in newborn infants with hyperbilirubinemia. Pediatrics. 1985;75:703-708
21. Ritter DA, Kenny JD, Norton HJ, Rudolph AJ. A prospective study of free bilirubin and other risk factors in the development of kernicterus in premature infants. Pediatrics. 1982;69:260-266
22. Nakamura H, Yonetani M, Uetani Y, Funato M, Lee Y. Determination of serum unbound bilirubin for prediction of kernicterus in low birth weight infants. Acta Paediatr Jpn. 1992;34:642-647
23. Cashore WJ, Oh W. Unbound bilirubin and kernicterus in low-birth-weight infants. Pediatrics. 1982;69:481-485
24. Robertson A, Karp W, Brodersen R. Bilirubin displacing effect of drugs used in neonatology. Acta Paediatr Scand. 1991;80:1119-1127
25. Robertson A, Brodersen R. Effect of drug combinations on bilirubin-albumin binding. Dev Pharmacol Ther. 1991;17:95-99
26. Rubin M, Harell D, Naor N, et al. Lipid infusion with different triglyceride cores: effect on plasma lipids and bilirubin binding in premature infants. J Parenter Enteral Nutr. 1991;15:642-646
27. Itoh S, Yamakawa T, Onishi S, Isobe K, Manabe M, Sasaki K. The effect of bilirubin photoisomers on unbound-bilirubin concentrations estimated by the peroxidase method. Biochem J. 1986;239:417-421
28. Ahlfors CE. Measurement of plasma unbound unconjugated bilirubin. Anal Biochem. 2000;279:130-135
29. Ahlfors CE, Marshall GD, Wolcott DK, Olson DC, VanOvermeire B. Measurement of unbound bilirubin by the peroxidase test using Zone Fluidics. Clin Chim Acta. 2006;365:78-85